Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
AstraZeneca
Chinese Patent Office
Teva
Johnson and Johnson
Citi
US Army
US Department of Justice
Express Scripts
Fish and Richardson

Generated: August 16, 2017

DrugPatentWatch Database Preview

Rabeprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rabeprazole sodium and what is the scope of rabeprazole sodium patent protection?

Rabeprazole sodium
is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Dr Reddys Labs Ltd, Fsc Therap, Breckenridge Pharm, Aurobindo Pharma Ltd, Lupin Ltd, Eisai Inc, Torrent Pharms Ltd, Kremers Urban Pharms, Amneal Pharms, and Mylan Pharms Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for rabeprazole sodium. Twenty-four suppliers are listed for this compound.

Summary for Generic Name: rabeprazole sodium

Tradenames:3
Patents:0
Applicants:11
NDAs:11
Drug Master File Entries: see list29
Suppliers / Packagers: see list24
Bulk Api Vendors: see list52
Clinical Trials: see list2,462
Patent Applications: see list958
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rabeprazole sodium at DailyMed

Pharmacology for Ingredient: rabeprazole sodium

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
RABEPRAZOLE SODIUM
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL076885-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
RABEPRAZOLE SODIUM
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL076824-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
RABEPRAZOLE SODIUM
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL204237-001Nov 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Fsc Therap
ACIPHEX SPRINKLE
rabeprazole sodium
CAPSULE, DELAYED RELEASE;ORAL204736-002Mar 26, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Lupin Ltd
RABEPRAZOLE SODIUM
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL078964-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: rabeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Eisai Inc
ACIPHEX
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL020973-002Aug 19, 1999► Subscribe► Subscribe
Fsc Therap
ACIPHEX SPRINKLE
rabeprazole sodium
CAPSULE, DELAYED RELEASE;ORAL204736-001Mar 26, 2013► Subscribe► Subscribe
Eisai Inc
ACIPHEX
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL020973-001May 29, 2002► Subscribe► Subscribe
Fsc Therap
ACIPHEX SPRINKLE
rabeprazole sodium
CAPSULE, DELAYED RELEASE;ORAL204736-002Mar 26, 2013► Subscribe► Subscribe
Eisai Inc
ACIPHEX
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL020973-001May 29, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Johnson and Johnson
US Department of Justice
Fish and Richardson
Cipla
Colorcon
Harvard Business School
Healthtrust
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot